Literature DB >> 7833585

Should folate supplementation be routinely recommended for older patients receiving methotrexate?

B F Leeb1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7833585     DOI: 10.2165/00002512-199405050-00001

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


× No keyword cloud information.
  18 in total

1.  Methotrexate in older patients with rheumatoid arthritis.

Authors:  P Poole; S Yeoman; D Caughey
Journal:  Br J Rheumatol       Date:  1992-12

Review 2.  Does folate supplementation make sense in patients with rheumatoid arthritis treated with methotrexate?

Authors:  A A Stenger; P M Houtman; G A Bruyn
Journal:  Ann Rheum Dis       Date:  1992-08       Impact factor: 19.103

3.  Methotrexate metabolism analysis in blood and liver of rheumatoid arthritis patients. Association with hepatic folate deficiency and formation of polyglutamates.

Authors:  J M Kremer; J Galivan; A Streckfuss; B Kamen
Journal:  Arthritis Rheum       Date:  1986-07

4.  Folate supplementation in methotrexate-treated rheumatoid arthritis patients.

Authors:  K A Stewart; A H Mackenzie; J D Clough; W S Wilke
Journal:  Semin Arthritis Rheum       Date:  1991-04       Impact factor: 5.532

5.  Methotrexate in rheumatoid arthritis. Toxic effects as the major factor in limiting long-term treatment.

Authors:  G S Alarcón; I C Tracy; W D Blackburn
Journal:  Arthritis Rheum       Date:  1989-06

6.  Administration of folinic acid after low dose methotrexate in patients with rheumatoid arthritis.

Authors:  L M Buckley; P M Vacek; S M Cooper
Journal:  J Rheumatol       Date:  1990-09       Impact factor: 4.666

7.  Elevated mean corpuscular volume as a predictor of hematologic toxicity due to methotrexate therapy.

Authors:  M E Weinblatt; P Fraser
Journal:  Arthritis Rheum       Date:  1989-12

8.  The effects of leucovorin (folinic acid) on methotrexate therapy in rheumatoid arthritis patients.

Authors:  M Tishler; D Caspi; B Fishel; M Yaron
Journal:  Arthritis Rheum       Date:  1988-07

9.  Long-term prospective trial of low-dose methotrexate in rheumatoid arthritis.

Authors:  M E Weinblatt; D E Trentham; P A Fraser; D E Holdsworth; K R Falchuk; B N Weissman; J S Coblyn
Journal:  Arthritis Rheum       Date:  1988-02

10.  The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis. Results of two metaanalyses.

Authors:  D T Felson; J J Anderson; R F Meenan
Journal:  Arthritis Rheum       Date:  1990-10
View more
  2 in total

Review 1.  Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis.

Authors:  B Bannwarth; F Péhourcq; T Schaeverbeke; J Dehais
Journal:  Clin Pharmacokinet       Date:  1996-03       Impact factor: 6.447

Review 2.  Elderly-onset sarcoidosis: prevalence, clinical course, and treatment.

Authors:  Yvan Jamilloux; Marc Bonnefoy; Dominique Valeyre; Loig Varron; Christiane Broussolle; Pascal Sève
Journal:  Drugs Aging       Date:  2013-12       Impact factor: 3.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.